Skip to main content

Table 1 Baseline characteristics of prospective clinical cohort

From: Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease

Demographics

Value

Number of participants

49

Age (years)

67 ± 9

Male/Female

32/17

Caucasian (%)

94

COPD-related variable

 

 LAMA use (n,%)

45 (91.8%)

 Inhaled corticosteroid use (n,%)

43 (87.5%)

 LABA use (n,%)

40 (81.6%)

 Current smoker (%)

57.1

 Smoking history (pack-years)

50 (39,63)

 Radiographic emphysema (%)

90.6

 Home O2 (%)

38.3

 FEV1 (L)

1.1 ± 0.47

 FEV1 (%Predicted)

41 ± 18

 Self-reported AECOPD in last 1-year

2 (0,4)

 Self-reported Admission for AECOPD in last 1-year

0 (0,1)

  1. LAMA long-acting muscarinic antagonist, FEV1 forced expiratory volume in 1-s, AECOPD acute exacerbation of chronic obstructive pulmonary disease